VRCA
#4062
Verrica Pharmaceuticals Inc. - Common Stock
3.6 6 USD
-0.09%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-8.73%
Variación mensual
-25.46%
Variación en los últimos 6 meses
-35.79%
Cambio anual
-39.20%
Cierres anteriores
4.0 1
Open
3.9 9
Mínimo
3.6 0
Máximo
4.3 8
Financials
- Market Capitalization 62.87 M
- Employee 76
- Founded 2013
- CEO Jayson Rieger
- Website www.verrica.com
- Headquarter Delaware, United States
- FIGI BBG00L03BYB7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.95
Relación precio/flujo de caja
2.49
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4054 |  RNTX Rein Therapeutics, Inc. - Common Stock | 0.76 USD | -2.56% | -7.32% | -5.00% | -30.93% | 65.56 M USD | ||
| 4061 |  GANX Gain Therapeutics, Inc. - Common Stock | 1.45 USD | -7.64% | -14.20% | -17.61% | -23.68% | 63.28 M USD | ||
| 4067 |  TENX Tenax Therapeutics, Inc. - Common Stock | 1.66 USD | -9.29% | -13.99% | -9.78% | -78.01% | 62.12 M USD | ||
| 4068 |  LONA LeonaBio, Inc. - Common Stock | 6.59 USD | +6.98% | +15.61% | -6.13% | -2.23% | 62.09 M USD |